Unknown

Dataset Information

0

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.

ABSTRACT: BACKGROUND:Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of low-density lipoprotein cholesterol and cardiovascular disease risk, and is an emerging therapeutic target. OBJECTIVE:We compared serum PCSK9 levels in young adults, with and without type 2 diabetes. SUBJECTS AND METHODS:Cross-sectional analysis was conducted in a cohort, aged 15 to 26?years, in Cincinnati, OH, from 2005 to 2010. Serum PCSK9 levels were measured in 94 youth with type 2 diabetes, 93 obese control subjects, and 99 lean control subjects. Correlative analyses were conducted to determine significant covariates of PCSK9 by group and sex, and multivariate linear regression models were used to study the independent determinants of PCSK9. RESULTS:In females, PCSK9 levels were significantly increased in the obese and type 2 diabetes subjects relative to the lean controls (P?

SUBMITTER: Levenson AE 

PROVIDER: S-EPMC5513789 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.

Levenson Amy E AE   Shah Amy S AS   Khoury Philip R PR   Kimball Thomas R TR   Urbina Elaine M EM   de Ferranti Sarah D SD   Maahs David M DM   Dolan Lawrence M LM   Wadwa R Paul RP   Biddinger Sudha B SB  

Pediatric diabetes 20170117 8

<h4>Background</h4>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of low-density lipoprotein cholesterol and cardiovascular disease risk, and is an emerging therapeutic target.<h4>Objective</h4>We compared serum PCSK9 levels in young adults, with and without type 2 diabetes.<h4>Subjects and methods</h4>Cross-sectional analysis was conducted in a cohort, aged 15 to 26 years, in Cincinnati, OH, from 2005 to 2010. Serum PCSK9 levels were measured in 94 youth with type 2 di  ...[more]

Similar Datasets

Unknown Are hemoglobin levels elevated in type 1 diabetes?
| S-EPMC2809278 | biostudies-literature
Unknown Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.
| S-EPMC7058975 | biostudies-literature
Unknown Serum bilirubin levels are positively associated with glycemic variability in women with type 2 diabetes.
| S-EPMC5089950 | biostudies-literature
Unknown Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps.
| S-EPMC5095649 | biostudies-literature
Unknown Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes.
| S-EPMC4174326 | biostudies-other
Unknown Persistently high glucose levels in young children with type 1 diabetes.
| S-EPMC4465416 | biostudies-literature
Unknown Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
| S-EPMC3405068 | biostudies-literature
Unknown Elevated serum growth differentiation factor 15 levels are associated with thyroid nodules in type 2 diabetes aged over 60 years.
| S-EPMC5522289 | biostudies-other
Unknown Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients.
| S-EPMC6319497 | biostudies-literature
Unknown Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes.
| S-EPMC7855867 | biostudies-literature